NGL Fine-Chem (NSE:NGLFINE) Cash-to-Debt : 2.01 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is NGL Fine-Chem Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. NGL Fine-Chem's cash to debt ratio for the quarter that ended in Sep. 2024 was 2.01.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, NGL Fine-Chem could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for NGL Fine-Chem's Cash-to-Debt or its related term are showing as below:

NSE:NGLFINE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.29 Med: 0.64 Max: 2.63
Current: 2.01

During the past 13 years, NGL Fine-Chem's highest Cash to Debt Ratio was 2.63. The lowest was 0.29. And the median was 0.64.

NSE:NGLFINE's Cash-to-Debt is ranked better than
60.04% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 0.94 vs NSE:NGLFINE: 2.01

NGL Fine-Chem Cash-to-Debt Historical Data

The historical data trend for NGL Fine-Chem's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

NGL Fine-Chem Cash-to-Debt Chart

NGL Fine-Chem Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

0.52

2.06

1.02

1.63

1.66

NGL Fine-Chem Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															2.63	N/A	1.66	N/A	2.01

Competitive Comparison of NGL Fine-Chem's Cash-to-Debt

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NGL Fine-Chem's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's Cash-to-Debt falls into.

NGL Fine-Chem Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

NGL Fine-Chem's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	562.901	/	(332.59	+	7.448)
	=	1.66

NGL Fine-Chem's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	989.908	/	(296.008	+	196.021)
	=	2.01

NGL Fine-Chem (NSE:NGLFINE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

NGL Fine-Chem Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

NGL Fine-Chem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (NSE:NGLFINE) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

524774:India

Address

301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057

Website

https://www.nglfinechem.com

NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem Headlines

No Headlines